Integrative Genome Comparison of Primary and Metastatic Melanomas

Diffuse Expression of RNA-Binding Protein IMP3 Predicts High-Stage Lymph Node Metastasis and Poor Prognosis in Colorectal Adenocarcinoma

(2009) Ray-Hwang Yuan et al.   ANNALS OF SURGICAL ONCOLOGY

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression

(2009) K. P. Hoeflich et al.   CANCER RESEARCH

NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development

(2009) E. Izumchenko et al.   CANCER RESEARCH

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

(2009) Otto Walter et al.   HUMAN PATHOLOGY

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer

(2009) Kenneth L. Scott et al.   NATURE

Copy number variation at 1q21.1 associated with neuroblastoma

(2009) Sharon J. Diskin et al.   NATURE

Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma

(2008) W. M. Lin et al.   CANCER RESEARCH

Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement

(2008) Victoria Sanz-Moreno et al.   CELL

Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas

(2008) Z. Jiang et al.   CLINICAL CANCER RESEARCH

IL-1β induces urokinse-plasminogen activator expression and cell migration through PKCα, JNK1/2, and NF-κB in A549 cells

(2008) Ching-Yi Cheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis

(2008) Bernd Frank et al.   JNCI-Journal of the National Cancer Institute

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

(2008) Catherine D. Van Raamsdonk et al.   NATURE